Tuesday, February 12 episode artwork

EPISODE · Feb 12, 2019 · 7 MIN

Tuesday, February 12

from FT News Briefing

Virgin looks to expand in the US, Theresa May is expected to ask MPs for more time to overhaul her Brexit deal and Merck releases trial data showing its drug Keytruda can help cut patients' risk of dying from kidney cancer in half. Plus, the FT's Ian Mount tells us what to expect as the Spanish Supreme Court trial of 12 Catalan separatists begins today in Madrid.  Hosted on Acast. See acast.com/privacy for more information.

Virgin looks to expand in the US, Theresa May is expected to ask MPs for more time to overhaul her Brexit deal and Merck releases trial data showing its drug Keytruda can help cut patients' risk of dying from kidney cancer in half. Plus, the FT's Ian Mount tells us what to expect as the Spanish Supreme Court trial of 12 Catalan separatists begins today in Madrid.  Hosted on Acast. See acast.com/privacy for more information.

NOW PLAYING

Tuesday, February 12

0:00 7:59

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of FT News Briefing?

This episode is 7 minutes long.

When was this FT News Briefing episode published?

This episode was published on February 12, 2019.

What is this episode about?

Virgin looks to expand in the US, Theresa May is expected to ask MPs for more time to overhaul her Brexit deal and Merck releases trial data showing its drug Keytruda can help cut patients' risk of dying from kidney cancer in half. Plus, the FT's...

Can I download this FT News Briefing episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!